Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subtotal Nodal Irradiation vs Doxorubicin/Vinblastine + Irradiation for Stage I-IIA Hodgkin's Disease
NCT00002495Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 1992
- Primary completion
- Nov 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin, vinblastine in Hodgkin lymphoma (HL), sponsored by SWOG Cancer Research Network. Started Sep 1992; status: completed.
02
Drugs
doxorubicinvinblastine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00002495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002495.